Early stage researchers, life science entrepreneurs, and companies are encouraged to apply starting May 2
Site Search
Showing 1 - 3 of 3 results
Press Release
|
|
6 min read
New modulators in development by the CF-specific company could provide unique treatment options for the underlying cause of cystic fibrosis for many people with the disease
Press Release
|
|
3 min read
A transformative leader for more than two decades, Marshall will transition to advisory role
News
|
|
3 min read